Published in J Virol on August 01, 1994
Animal pneumoviruses: molecular genetics and pathogenesis. Clin Microbiol Rev (2004) 1.67
Versatility of the accessory C proteins of Sendai virus: contribution to virus assembly as an additional role. J Virol (2000) 1.33
Expression of the ORF-2 protein of the human respiratory syncytial virus M2 gene is initiated by a ribosomal termination-dependent reinitiation mechanism. EMBO J (2000) 1.32
The various Sendai virus C proteins are not functionally equivalent and exert both positive and negative effects on viral RNA accumulation during the course of infection. J Virol (1998) 1.27
Identification of a novel virulence factor in recombinant pneumonia virus of mice. J Virol (2007) 1.08
Coupled translation of the second open reading frame of M2 mRNA is sequence dependent and differs significantly within the subfamily Pneumovirinae. J Virol (2007) 1.01
Reevaluation of the virulence of prototypic strain 15 of pneumonia virus of mice. J Virol (2004) 0.96
Molecular differences between two Jeryl Lynn mumps virus vaccine component strains, JL5 and JL2. J Gen Virol (2009) 0.87
Evaluation of pneumonia virus of mice as a possible human pathogen. J Virol (2012) 0.80
Identification of a truncated nucleoprotein in avian metapneumovirus-infected cells encoded by a second AUG, in-frame to the full-length gene. Virol J (2005) 0.75
Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science (1985) 95.08
Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. J Mol Biol (1980) 61.16
Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol (1986) 55.34
CLUSTAL: a package for performing multiple sequence alignment on a microcomputer. Gene (1988) 42.41
New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates. Biochemistry (1979) 5.02
Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins. Nucleic Acids Res (1983) 3.62
Measles virus P gene codes for two proteins. J Virol (1985) 3.31
The envelope-associated 22K protein of human respiratory syncytial virus: nucleotide sequence of the mRNA and a related polytranscript. J Virol (1985) 2.15
The P gene of human parainfluenza virus type 1 encodes P and C proteins but not a cysteine-rich V protein. J Virol (1991) 1.64
Sequence analysis of the 22K, SH and G genes of turkey rhinotracheitis virus and their intergenic regions reveals a gene order different from that of other pneumoviruses. J Gen Virol (1992) 1.57
Sequence analysis of the P and C protein genes of human parainfluenza virus type 3: patterns of amino acid sequence homology among paramyxovirus proteins. J Gen Virol (1986) 1.43
Nucleotide sequence of the fusion and phosphoprotein genes of human respiratory syncytial (RS) virus Long strain: evidence of subtype genetic heterogeneity. Virus Res (1988) 1.23
Sequence analysis of the phosphoprotein (P) genes of human parainfluenza type 4A and 4B viruses and RNA editing at transcript of the P genes: the number of G residues added is imprecise. Virology (1990) 1.20
Sequence analysis of the gene encoding the fusion glycoprotein of pneumonia virus of mice suggests possible conserved secondary structure elements in paramyxovirus fusion glycoproteins. J Gen Virol (1992) 1.16
Molecular cloning and sequence analysis of the human parainfluenza 3 virus mRNA encoding the P and C proteins. Virology (1986) 1.12
The P protein and the nonstructural 38K and 29K proteins of Newcastle disease virus are derived from the same open reading frame. Virology (1988) 1.08
Sequence comparison between the phosphoprotein mRNAs of human and bovine respiratory syncytial viruses identifies a divergent domain in the predicted protein. J Gen Virol (1992) 1.05
Sequence analysis of the respiratory syncytial virus phosphoprotein gene. J Virol (1984) 1.03
Polypeptides of pneumonia virus of mice. I. Immunological cross-reactions and post-translational modifications. J Gen Virol (1989) 0.97
Murine pneumonia virus: seroepidemiological evidence of widespread human infection. J Gen Virol (1986) 0.93
Sequence comparison of the phosphoprotein mRNAs of antigenic subgroups A and B of human respiratory syncytial virus identifies a highly divergent domain in the predicted protein. J Gen Virol (1990) 0.92
The nucleotide sequences of intergenic regions between nine genes of pneumonia virus of mice establish the physical order of these genes in the viral genome. Virus Res (1991) 0.89
Nucleotide sequence of the respiratory syncytial virus phosphoprotein gene. J Gen Virol (1985) 0.86
Genes 1 and 2 of pneumonia virus of mice encode proteins which have little homology with the 1C and 1B proteins of human respiratory syncytial virus. J Gen Virol (1991) 0.85
Molecular cloning of pneumonia virus of mice. J Virol (1990) 0.81
Genetic characteristics of conditional lethal mutants of vesicular stomatitis virus induced by 5-fluorouracil, 5-azacytidine, and ethyl methane sulfonate. J Virol (1970) 5.43
Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J Gen Virol (1990) 3.59
The homologies of spontaneous and induced temperature-sensitive mutants of vesicular stomatitis virus isolated in chick embryo and BHK 21 cells. J Gen Virol (1971) 2.35
Recombination between conditional lethal mutants within a strain of foot-and-mouth disease virus. J Gen Virol (1968) 2.30
Effect of temperature-sensitive mutations on the virion-associated RNA transcriptase of vesicular stomatitis virus. J Mol Biol (1972) 2.23
Virus replication in enucleate cells: vesicular stomatitis virus and influenza virus. J Virol (1974) 2.19
Defective particles in BHK cells infected with temperature-sensitive mutants of vesicular stomatitis virus. J Virol (1971) 2.14
Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein. J Gen Virol (1997) 2.13
Respiratory syncytial virus proteins. Virology (1976) 2.11
Preliminary physiological characterization of temperature-sensitive mutants of vesicular stomatitis virus. J Virol (1971) 2.11
Evolution of subgroup A respiratory syncytial virus: evidence for progressive accumulation of amino acid changes in the attachment protein. J Virol (1995) 2.10
Expression of hTERT immortalises normal human urothelial cells without inactivation of the p16/Rb pathway. Oncogene (2006) 2.03
Immediate-early mRNA-2 of herpes simplex viruses types 1 and 2 is unspliced: conserved sequences around the 5' and 3' termini correspond to transcription regulatory signals. Nucleic Acids Res (1983) 2.01
Isolation and characterization of temperature-sensitive mutants of vesicular stomatitis virus, New Jersey serotype. J Virol (1971) 1.97
Phenotypic consequences of rearranging the P, M, and G genes of vesicular stomatitis virus. J Virol (1999) 1.89
Virus taxonomy--1999. The universal system of virus taxonomy, updated to include the new proposals ratified by the International Committee on Taxonomy of Viruses during 1998. Arch Virol (1999) 1.80
Virus taxonomy--1997. J Gen Virol (1998) 1.79
Identification of variable domains of the attachment (G) protein of subgroup A respiratory syncytial viruses. J Gen Virol (1991) 1.79
The chemokine macrophage-inflammatory protein-1 alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection. J Immunol (2000) 1.75
Analysis of respiratory syncytial virus strain variation in successive epidemics in one city. J Clin Microbiol (1994) 1.72
Synthesis of bunyavirus-specific proteins in a continuous cell line (XTC-2) derived from Xenopus laevis. J Gen Virol (1985) 1.68
Antigen and polypeptide synthesis by temperature-sensitive mutants of respiratory syncytial virus. J Gen Virol (1981) 1.63
Comparisons of nucleotide sequences in the genomes of the New Jersey and Indiana serotypes of vesicular stomatitis virus. J Virol (1980) 1.61
Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance. Int J Cancer (1988) 1.59
Sequence analysis of the 22K, SH and G genes of turkey rhinotracheitis virus and their intergenic regions reveals a gene order different from that of other pneumoviruses. J Gen Virol (1992) 1.57
Conditional lethal mutants of vesicular stomatitis virus. Curr Top Microbiol Immunol (1975) 1.56
Focal changes in nerve, muscle and connective tissue in normal and unstable human bladder. BJU Int (1999) 1.55
Respiratory syncytial virus heterogeneity during an epidemic: analysis by limited nucleotide sequencing (SH gene) and restriction mapping (N gene). J Gen Virol (1991) 1.50
Protein synthesis in BHK21 cells infected with vesicular stomatitis virus. I. ts Mutants of the Indiana serotype. Virology (1972) 1.50
Virus development in enucleate cells: echovirus, poliovirus, pseudorabies virus, reovirus, respiratory syncytial virus and Semliki Forest virus. J Gen Virol (1975) 1.49
Jephcott Lecture. Full employment and incentives in a healthy society. Proc R Soc Med (1966) 1.47
Temporal regulation of herpes simplex virus type 2 transcription and characterization of virus immediate early mRNA's. Nucleic Acids Res (1980) 1.45
The tdCE and hrCE phenotypes: host range mutants of vesicular stomatitis virus in which polymerase function is affected. Cell (1978) 1.44
A peptide corresponding to the neuropilin-1-binding site on VEGF(165) induces apoptosis of neuropilin-1-expressing breast tumour cells. Br J Cancer (2005) 1.39
Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer. Lancet (1989) 1.37
Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer. Br J Cancer (1988) 1.37
Enhanced mutability associated with a temperature-sensitive mutant of vesicular stomatitis virus. J Virol (1981) 1.36
Nucleotide sequence of the Bunyamwera virus M RNA segment: conservation of structural features in the Bunyavirus glycoprotein gene product. Virology (1986) 1.35
A comparison of the polypeptides of human and bovine respiratory syncytial viruses and murine pneumonia virus. Virology (1977) 1.33
Proteinase-activated receptor-2: expression by human neutrophils. J Cell Sci (1997) 1.33
Nucleotide sequence of the gene encoding the fusion glycoprotein of Newcastle disease virus. J Gen Virol (1986) 1.33
Expression of the ORF-2 protein of the human respiratory syncytial virus M2 gene is initiated by a ribosomal termination-dependent reinitiation mechanism. EMBO J (2000) 1.32
Analysis of relatedness of subgroup A respiratory syncytial viruses isolated worldwide. Virus Res (1992) 1.30
Molecular epidemiology of respiratory syncytial virus: rapid identification of subgroup A lineages. J Virol Methods (1992) 1.29
Promoter-specific transactivation of hepatitis B virus transcription by a glutamine- and proline-rich domain of hepatocyte nuclear factor 1. J Virol (1991) 1.28
The polypeptides of human respiratory syncytial virus: products of cell-free protein synthesis and post-translational modifications. Virology (1979) 1.27
Differentiation-specific transcriptional regulation of the hepatitis B virus large surface antigen gene in human hepatoma cell lines. J Virol (1990) 1.26
Pulmonary eosinophilia and production of MIP-1alpha are prominent responses to infection with pneumonia virus of mice. Cell Immunol (2000) 1.25
Seven complementation groups of respiratory syncytial virus temperature-sensitive mutants. J Virol (1978) 1.22
Extensive sequence variation in the attachment (G) protein gene of avian pneumovirus: evidence for two distinct subgroups. J Gen Virol (1994) 1.22
Role of SPECT in differentiating malignant from benign lesions in the lower thoracic and lumbar vertebrae. Radiology (1993) 1.22
Virion trascriptase activity differences in host range mutants of vesicular stomatitis virus. J Virol (1975) 1.21
Detection and characterization of proteins encoded by the second ORF of the M2 gene of pneumoviruses. J Gen Virol (1999) 1.21
A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes. Mol Endocrinol (1999) 1.21
Bunyamwera virus-induced polypeptide synthesis. J Virol (1977) 1.18
Pathogenesis of pneumovirus infections in mice: detection of pneumonia virus of mice and human respiratory syncytial virus mRNA in lungs of infected mice by in situ hybridization. J Gen Virol (1998) 1.17
Nucleotide sequences of the genes encoding the putative attachment glycoprotein (G) of mouse and tissue culture-passaged strains of pneumonia virus of mice. Virology (1995) 1.17
Comparison of structural polypeptides from vesicular stomatitis virus (Indiana and New Jersey serotypes) and Cocal virus. J Gen Virol (1972) 1.17
The integration of HPV-18 DNA in cervical carcinoma. Mol Pathol (1999) 1.17
The genetics of vesiculoviruses. Arch Virol (1982) 1.16
Sequence analysis of the gene encoding the fusion glycoprotein of pneumonia virus of mice suggests possible conserved secondary structure elements in paramyxovirus fusion glycoproteins. J Gen Virol (1992) 1.16
Genome subunit reassortment among Bunyaviruses analysed by dot hybridization using molecularly cloned complementary DNA probes. Virology (1984) 1.16
Respiratory syncytial virus ts mutants and nuclear immunofluorescence. J Virol (1976) 1.15
Temperature-sensitive mutants of complementation group E of vesicular stomatitis virus New Jersey serotype possess altered NS polypeptides. J Virol (1979) 1.15
Rescue of synthetic minireplicons establishes the absence of the NS1 and NS2 genes from avian pneumovirus. J Virol (1997) 1.15
Nucleotide sequence of the fusion and haemagglutinin-neuraminidase glycoprotein genes of Newcastle disease virus, strain Ulster: molecular basis for variations in pathogenicity between strains. J Gen Virol (1988) 1.14
Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1. Antivir Chem Chemother (1999) 1.13
Identification of mutations contributing to the reduced virulence of a modified strain of respiratory syncytial virus. Vaccine (1996) 1.11
Expression and characterisation of the NS1 and NS2 proteins of respiratory syncytial virus. Virus Res (1996) 1.11
Effect of temperature-sensitive mutation on activity of the RNA transcriptase of vesicular stomatitis virus New Jersey. J Virol (1979) 1.09
Nucleotide sequence of the gene encoding the matrix protein of Newcastle disease virus. Nucleic Acids Res (1986) 1.09
Analysis of the human serological immune response to a variable region of the attachment (G) protein of respiratory syncytial virus during primary infection. J Med Virol (1996) 1.09
Temperature-sensitive mutants of vesicular stomatitis virus; homology and nomenclature. J Gen Virol (1973) 1.08
Identification of potential activators of proteinase-activated receptor-2. FEBS Lett (1997) 1.07
Genetic interactions among viruses of the Bunyamwera complex. J Virol (1981) 1.07
Streptokinase-induced platelet activation involves antistreptokinase antibodies and cleavage of protease-activated receptor-1. Blood (2000) 1.07
A temperature-sensitive mutant of vesicular stomatitis virus with two abnormal virus proteins. J Gen Virol (1974) 1.07
Genetic and physiological properties of temperature-sensitive mutants of Cocal virus. J Virol (1973) 1.07
Rhabdoviridae. Report of the Rhabdovirus Study Group, International Committee on Taxonomy of Viruses. Intervirology (1979) 1.07
Molecular cloning of complementary DNA to Newcastle disease virus, and nucleotide sequence analysis of the junction between the genes encoding the haemagglutinin-neuraminidase and the large protein. J Gen Virol (1986) 1.05
Importance of the P4' residue in human granzyme B inhibitors and substrates revealed by scanning mutagenesis of the proteinase inhibitor 9 reactive center loop. J Biol Chem (2001) 1.05
Immunolocalization of protease-activated receptor-2 in skin: receptor activation stimulates interleukin-8 secretion by keratinocytes in vitro. Immunology (1998) 1.05
A sequence within the cytoplasmic tail of GpIIb independently activates platelet aggregation and thromboxane synthesis. J Biol Chem (1998) 1.04
Characterization of the interaction of the human respiratory syncytial virus phosphoprotein and nucleocapsid protein using the two-hybrid system. Virus Res (1998) 1.04
Identification of the Escherichia coli recN gene product as a major SOS protein. J Bacteriol (1985) 1.04
Termperature-sensitive mutants of pseudorabies virus with differential effects on viral and host DNA synthesis. Virology (1973) 1.04
The order Mononegavirales--current status. Arch Virol (1997) 1.04
Action of interferon in enucleated cells. J Virol (1975) 1.03
The N-terminal region of non-A beta component of Alzheimer's disease amyloid is responsible for its tendency to assume beta-sheet and aggregate to form fibrils. Eur J Biochem (1998) 1.03
Nucleotide sequence of the gene encoding the viral polymerase of avian pneumovirus. J Gen Virol (1996) 1.02
EGFR mutations in exons 18-21 in sporadic breast cancer. Ann Oncol (2007) 1.02